Prospective Study of Placental Angiogenic Factors and Maternal Vascular Function Before and After Preeclampsia and Gestational Hypertension

First-Trimester Prediction of Hypertensive Disorders in Pregnancy

(2009) Leona C.Y. Poon et al.   HYPERTENSION

Risk of pre-eclampsia in first and subsequent pregnancies: prospective cohort study

(2009) S. Hernandez-Diaz et al.   BMJ-British Medical Journal

Secular Trends in the Rates of Preeclampsia, Eclampsia, and Gestational Hypertension, United States, 1987-2004

(2008) A. B. Wallis et al.   AMERICAN JOURNAL OF HYPERTENSION

Endoglin in angiogenesis and vascular diseases

(2008) Peter ten Dijke et al.   ANGIOGENESIS

Potential Role for Plasma Placental Growth Factor in Predicting Coronary Heart Disease Risk in Women

(2008) Aedín Cassidy et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Adverse Perinatal Outcomes and Risk Factors for Preeclampsia in Women With Chronic Hypertension

(2008) Lucy C. Chappell et al.   HYPERTENSION

A longitudinal study of angiogenic (placental growth factor) and anti-angiogenic (soluble endoglin and soluble vascular endothelial growth factor receptor-1) factors in normal pregnancy and patients destined to develop preeclampsia and deliver a small for gestational age neonate

(2008) Roberto Romero et al.   Journal of Maternal-Fetal & Neonatal Medicine

Methodological Approaches to Optimize Reproducibility and Power in Clinical Studies of Flow-Mediated Dilation

(2008) Ann E. Donald et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Maternal endothelial function and serum concentrations of placental growth factor and soluble endoglin in women with abnormal placentation

(2008) M. D. Savvidou et al.   ULTRASOUND IN OBSTETRICS & GYNECOLOGY

Preeclampsia and Angiogenic Imbalance

(2007) Sharon Maynard et al.   Annual Review of Medicine